Douglas S. Micalizzi

3.4k citations
25 papers · 2.4k indexed · 1 hit paper · h-index 14
Topics
Cancer Cells and Metastasis (11 papers)Cancer Genomics and Diagnostics (5 papers)Advanced Breast Cancer Therapies (4 papers)
Partner nations
United StatesBrazil

In The Last Decade

Douglas S. Micalizzi

25 papers receiving 2.3k citations

Hit Papers

Epithelial-Mesenchymal Transition in Cancer: Parallels Be...20102026201520202010250500750

Peers

Douglas S. Micalizzi
Comparison fields: 5 of 106
  • Molecular Biology 1.6k
  • Oncology 1.2k
  • Cancer Research 841
  • Pulmonary and Respiratory Medicine 293
  • Cell Biology 206
Replace Joseph H. Taube with:
Joseph H. Taube United States
Hyejin Choi United States
Theresa LaVallee United States
Mingxia Yan China
Daniel Escuín Spain
Ray Somcio United States
Xiaofeng Zheng United States
Greg H. Enders United States
Anna Durrans United States
Tina El Rayes United States
Douglas S. Micalizzi relative to Joseph H. Taube United States Joseph H. Taube's profile →
Citations per field
00.5×1.5×
Joseph H. Taube · 1×
Citations per year

Countries citing papers authored by Douglas S. Micalizzi

Since Specialization
Citations

This map shows the geographic impact of Douglas S. Micalizzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas S. Micalizzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas S. Micalizzi more than expected).

Fields of papers citing papers by Douglas S. Micalizzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas S. Micalizzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas S. Micalizzi. The network helps show where Douglas S. Micalizzi may publish in the future.

Co-authorship network of co-authors of Douglas S. Micalizzi

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas S. Micalizzi. A scholar is included among the top collaborators of Douglas S. Micalizzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas S. Micalizzi. Douglas S. Micalizzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 5
5 13
6 65
7 329
8 2
9 50
10 1
11 255
12 99
13 2
14 107
15 92
16
Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progressionbreakdown →
765
17 196
18 118
19 84
20 4

About Douglas S. Micalizzi

Douglas S. Micalizzi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 25 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (11 papers), Cancer Genomics and Diagnostics (5 papers) and Advanced Breast Cancer Therapies (4 papers). The work is most often cited by research in Cancer Research (841 citations), Oncology (1.2k citations) and Molecular Biology (1.6k citations). Douglas S. Micalizzi has collaborated with scholars based in United States and Brazil. Frequent co-authors include Heide L. Ford, Susan M. Farabaugh, Shyamala Maheswaran, Daniel A. Haber, Paul Jedlicka, Ritsuko Iwanaga, Aik Choon Tan, David Drasin, J. Chuck Harrell and Rebecca L. Vartuli. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026